These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 677864)

  • 21. Biliary excretion and concentration of cefazolin.
    Ram MD; Watanatittan S
    Am J Gastroenterol; 1976 Dec; 66(6):540-5. PubMed ID: 1020741
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Excretion of cefamandole in the bile.
    Lindahl F; Kjaer TB; Thomsen VF
    Scand J Infect Dis Suppl; 1980; suppl 25():58-9. PubMed ID: 6937953
    [No Abstract]   [Full Text] [Related]  

  • 23. On the pharmacokinetics of cephalosporin antibiotics.
    Andersson KE
    Scand J Infect Dis Suppl; 1978; (13):37-46. PubMed ID: 278145
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Penetration of cefamandole, cephalothin, and desacetylcephalothin into fibrin clots.
    Bergeron MG; Nguyen BM; Trottier S; Gauvreau L
    Antimicrob Agents Chemother; 1977 Dec; 12(6):682-7. PubMed ID: 931366
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Application of cephalosporins to obstetrics and gynecology: transfer of cefazolin and cephalothin to uterine tissue.
    Yamada N; Kido K; Uchida H; Yano J; Sagawa N; Hayashi S
    Am J Obstet Gynecol; 1980 Apr; 136(8):1036-40. PubMed ID: 7369254
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The pharmacokinetic studies of cephalothin, cefazolin and cefmetazole in the neonates and the premature babies.
    Sakata Y
    Kurume Med J; 1980; 27(4):275-98. PubMed ID: 6946258
    [No Abstract]   [Full Text] [Related]  

  • 27. The biliary excretion of cefazolin.
    Brogard JM; Dorner M; Pinget M; Adloff M; Lavillaureix J
    J Infect Dis; 1975 Jun; 131(6):625-33. PubMed ID: 805810
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cefamandole bile levels in patients with hepatobiliary disease.
    Uwaydah M; Kantarjian H; Osseiran M; Bal'a F
    Antimicrob Agents Chemother; 1982 Dec; 22(6):1087-9. PubMed ID: 7159070
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biliary levels of ceforanide.
    Kenady DE; Ram MD
    Antimicrob Agents Chemother; 1983 May; 23(5):706-9. PubMed ID: 6870219
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Excretion of cephalothin and cefamandole by the normal pancreas and in acute pancreatitis in dogs.
    Studley JG; Schentag JJ; Schenk WG
    Antimicrob Agents Chemother; 1982 Aug; 22(2):262-5. PubMed ID: 6927287
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro activity and clinical pharmacology of cefamandole in comparison to cephalothin.
    Simon VC; Malerczyk V; Nixdorf F
    J Antimicrob Chemother; 1978 Jan; 4(1):85-90. PubMed ID: 624694
    [No Abstract]   [Full Text] [Related]  

  • 32. Pharmacokinetic interpretation of blood levels and urinary excretion data for cefazolin and cephalothin after intravenous and intramuscular administration in humans.
    Rattie ES; Ravin LJ
    Antimicrob Agents Chemother; 1975 May; 7(5):606-13. PubMed ID: 1147591
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The lack of inactivation of tobramycin by cefazolin, cefamandole, and moxalactam in vitro.
    Earp CM; Barriere SL
    Drug Intell Clin Pharm; 1985 Sep; 19(9):677-9. PubMed ID: 4042863
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacological study of cefazolin during intermittent and continuous infusion: a crossover investigation in humans.
    Thys JP; Vanderkelen B; Klastersky J
    Antimicrob Agents Chemother; 1976 Sep; 10(3):395-8. PubMed ID: 984782
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bone and serum concentrations of five cephalosporin drugs. Relevance to prophylaxis and treatment in orthopedic surgery.
    Williams DN; Gustilo RB; Beverly R; Kind AC
    Clin Orthop Relat Res; 1983 Oct; (179):253-65. PubMed ID: 6617025
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative pharmacokinetics of cefamandole, cephapirin, and cephalothin in healthy subjects and effect of repeated dosing.
    Barza M; Melethil S; Berger S; Ernst EC
    Antimicrob Agents Chemother; 1976 Sep; 10(3):421-5. PubMed ID: 984783
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical pharmacology of cefamandole as compared with cephalothin.
    Fong IW; Ralph ED; Engelking ER; Kirby WM
    Antimicrob Agents Chemother; 1976 Jan; 9(1):65-9. PubMed ID: 1259393
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics of cefamandole in rabbits with experimentally induced renal impairment.
    Campillo JA; Dominguez-Gil AA; Cepeda M; Dominguez-Gil A
    J Antibiot (Tokyo); 1980 Mar; 33(3):322-7. PubMed ID: 7380743
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Chemotherapy of bile duct infections. VIII. Studies on biliary excretion of cefamandole (author's transl)].
    Tanimura H; Takenaka M; Hikasa Y; Hashino H; Rai F; Kataoka S; Sato T
    Jpn J Antibiot; 1979 Oct; 32(10):1049-55. PubMed ID: 513287
    [No Abstract]   [Full Text] [Related]  

  • 40. Efficacy of prophylactic antibiotics in vascular surgery: an arterial wall microbiologic and pharmacokinetic perspective.
    Lalka SG; Malone JM; Fisher DF; Bernhard VM; Sullivan D; Stoeckelmann D; Bergstrom RF
    J Vasc Surg; 1989 Nov; 10(5):501-9; discussion 509-10. PubMed ID: 2810536
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.